Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy.
Hypericin, a polycyclic quinone derived from *Hypericum perforatum* (St.
APA
Ma H, Zhang X, et al. (2026). Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy.. Drug design, development and therapy, 20, 558923. https://doi.org/10.2147/DDDT.S558923
MLA
Ma H, et al.. "Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy.." Drug design, development and therapy, vol. 20, 2026, pp. 558923.
PMID
41836521
Abstract
Hypericin, a polycyclic quinone derived from *Hypericum perforatum* (St. John's Wort), has gained attention for its broad pharmacological activities, including anti-inflammatory, antimicrobial, and antitumor effects. It modulates key signaling pathways like NF-κB and MAPK, reducing chronic inflammation and making it effective in treating autoimmune and infectious skin conditions. As a photosensitizer, hypericin also induces apoptosis in abnormal cells through photodynamic therapy (PDT), showing promising results in treating cutaneous T-cell lymphoma (CTCL), psoriasis, and fungal infections. While its solubility and bioavailability remain challenges, hypericin's favorable safety profile and therapeutic potential position it as a valuable option for managing refractory dermatological conditions.
MeSH Terms
Humans; Perylene; Photochemotherapy; Anthracenes; Photosensitizing Agents; Animals; Immunologic Factors; Skin Diseases; Immunomodulating Agents
같은 제1저자의 인용 많은 논문 (5)
- Pan-cancer analysis and breast cancer validation reveal DEAD-box helicase 23 as a crucial prognostic and immuno-biomarker.
- An integrative multi-omics analysis leveraging Mendelian randomization and subsequent experimental validation prioritizes glutathione S-transferase mu 5 (GSTM5) as a genomic stability-related gene and a therapeutic vulnerability to PLK1 inhibition in breast cancer.
- Integrated design and application of metal-organic frameworks in ferroptosis-mediated cancer therapy.
- Drug screening reveals the mechanism of toyocamycin-induced apoptosis in triple-negative breast cancer organoids.
- Contrast-enhanced ultrasound-guided liver biopsy with flow cytometry analysis for the diagnosis of secondary hemophagocytic syndrome: A case report.